Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jeffrey J. Rohde is active.

Publication


Featured researches published by Jeffrey J. Rohde.


Tetrahedron Letters | 1997

The application of the formyl CH--O hydrogen bond postulate to the understanding of enantioselective reactions involving chiral boron lewis acids and aldehydes

E. J. Corey; Jeffrey J. Rohde

Abstract A number of noteworthy enantioselective reactions involving a variety of chiral boron Lewis acids and aldehydes can be rationalized in terms of the occurrence of formyl CH--O hydrogen bonds in the transition states and the additional three-dimensional organization which they provide.


Tetrahedron Letters | 1997

A HYPOTHESIS FOR CONFORMATIONAL RESTRICTION IN COMPLEXES OF FORMYL COMPOUNDS WITH BORON LEWIS ACIDS. EXPERIMENTAL EVIDENCE FOR FORMYL CH--O AND CH--F HYDROGEN BONDS

E. J. Corey; Jeffrey J. Rohde; Axel Fischer; Mihai D. Azimioara

X-ray crystallographic analysis of six complexes of formyl compounds with BF or BO containing boron Lewis acids reveals in every case a geometric preference for a conformation in which the formyl group and the BF or BO bond are coplanar, or nearly so.


The Journal of Neuroscience | 2011

Acute Inhibition of 11β-Hydroxysteroid Dehydrogenase Type-1 Improves Memory in Rodent Models of Cognition

Eric G. Mohler; Kaitlin E. Browman; Victoria A. Roderwald; Elizabeth A. Cronin; Stella Markosyan; R. Scott Bitner; Marina I. Strakhova; Karla Drescher; Wilfried Hornberger; Jeffrey J. Rohde; Michael E. Brune; Peer B. Jacobson; Lynne E. Rueter

Mounting evidence suggests excessive glucocorticoid activity may contribute to Alzheimers disease (AD) and age-associated memory impairment. 11β-hydroxysteroid dehydrogenase type-1 (HSD1) regulates conversion of glucocorticoids from inactive to active forms. HSD1 knock-out mice have improved cognition, and the nonselective inhibitor carbenoxolone improved verbal memory in elderly men. Together, these data suggest that HSD1 inhibition may be a potential therapy for cognitive deficits, such as those associated with AD. To investigate this, we characterized two novel and selective HSD1 inhibitors, A-918446 and A-801195. Learning, memory consolidation, and recall were evaluated in mouse 24 h inhibitory avoidance. Inhibition of brain cortisol production and phosphorylation of cAMP response element-binding protein (CREB), a transcription factor involved in cognition, were also examined. Rats were tested in a short-term memory model, social recognition, and in a separate group cortical and hippocampal acetylcholine release was measured via in vivo microdialysis. Acute treatment with A-801195 (10–30 mg/kg) or A-918446 (3–30 mg/kg) inhibited cortisol production in the ex vivo assay by ∼35–90%. Acute treatment with A-918446 improved memory consolidation and recall in inhibitory avoidance and increased CREB phosphorylation in the cingulate cortex. Acute treatment with A-801195 significantly improved short-term memory in rat social recognition that was not likely due to alterations of the cholinergic system, as acetylcholine release was not increased in a separate set of rats. These studies suggest that selective HSD1 inhibitors work through a novel, noncholinergic mechanism to facilitate cognitive processing.


Tetrahedron Letters | 2003

An efficient one-pot synthesis of substituted 2-arylbenzo[b]thiophene derivatives

Meena V Patel; Jeffrey J. Rohde; Vijaya Gracias; Teodozyj Kolasa

Abstract This communication describes an efficient one-pot procedure for the synthesis of 2-arylbenzo[ b ]thiophene derivatives via reaction of o -halo or nitro aryl carbonyl compounds with benzyl mercaptans in the presence of an excess of anhydrous K 2 CO 3 at elevated temperature.


Journal of the American Chemical Society | 1996

A Novel Chiral Super-Lewis Acidic Catalyst for Enantioselective Synthesis

Yujiro Hayashi; Jeffrey J. Rohde; E. J. Corey


Archive | 2006

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

Jeffrey J. Rohde; Qi Shuai; James T. Link; Jyoti R. Patel; Jurgen Dinges; Bryan K. Sorensen; Hong Yong; Vince S.C. Yeh; Ravi Kurukulasuriya


Archive | 2003

Prostaglandin endoperoxide H synthase biosynthesis inhibitors

Lawrence A. Black; Anwer Basha; Teodozyj Kolasa; Michael E. Kort; Huaqing Liu; Catherine M. Mccarty; Meena V. Patel; Jeffrey J. Rohde; Michael J. Coghlan; Andrew O. Stewart


Journal of Medicinal Chemistry | 2007

Discovery and Metabolic Stabilization of Potent and Selective 2-Amino-N-(adamant-2-yl) Acetamide 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors

Jeffrey J. Rohde; Marina A. Pliushchev; Bryan K. Sorensen; Dariusz Wodka; Qi Shuai; Jiahong Wang; Steven Fung; Katina Monzon; William J. Chiou; Liping Pan; Xiaoqing Deng; Linda E. Chovan; Atul Ramaiya; Mark M. Mullally; Rodger F. Henry; DeAnne Stolarik; Hovis M. Imade; Kennan C. Marsh; David W. A. Beno; Thomas A. Fey; Brian A. Droz; Michael E. Brune; Heidi S. Camp; Hing L. Sham; Ernst U. Frevert; Peer B. Jacobson; James T. Link


Journal of Medicinal Chemistry | 2004

Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunction

Marlon D. Cowart; Steven P. Latshaw; Pramila Bhatia; Jerome F. Daanen; Jeffrey J. Rohde; Sherry L. Nelson; Meena Patel; Teodozyi Kolasa; Masaki Nakane; Marie E. Uchic; Loan N. Miller; Marc A. Terranova; Renjie Chang; Diana L. Donnelly-Roberts; Marian T. Namovic; Peter R. Hollingsworth; Brenda R. Martino; James J. Lynch; James P. Sullivan; Gin C. Hsieh; Robert B. Moreland; Jorge D. Brioni; Andrew O. Stewart


Archive | 2008

Treatment of central nervous system disorders

R. Scott Bitner; Kaitlin E. Browman; Michael E. Brune; Yixian Chen; Jurgen Dinges; Karla Drescher; Peer B. Jacobson; Hwan-Soo Jae; Ravi Kurukulasuriya; James T. Link; David J. Madar; Jyoti R. Patel; Marina A. Pliushchev; Jeffrey J. Rohde; Lynne E. Rueter; Qi Shuai; Bryan K. Sorensen; Jiahong Wang; Karsten Wicke; Martin Winn; Dariusz Wodka; Vince Yeh; Hong Yong

Collaboration


Dive into the Jeffrey J. Rohde's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Martin Winn

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dariusz Wodka

Millennium Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge